Molekuliarnaia biologiiaHumansSertralinePrecision MedicineMaleCytochrome P-450 CYP2D6
[Personalized Pharmacotherapy with Sertraline in Patients with Anxiety-Depressive Disorder Based on Omics Biomarkers].
A E Gareeva, T R Nasibullin, S A Pozdnyakov, L S Borodina, I F Timerbulatov, N V Baymeeva, D E Bagaev, V V Smirnov
Published: 202510.7868/S3034555325060041
Abstract
Sertraline, a selective serotonin reuptake inhibitor, is widely used as a first-line drug for anxiety and depressive disorders. The clinical efficacy and adverse reactions observed with antidepressants are closely related to the concentration of this…
Preview only. Read the full abstract at the source